Hence, the occurrence and development of preeclampsia may be owing to the abnormal regulation of FLT1P1 and FLT1 expression; this indicates that FLT1P1 and FLT1 are promising biomarkers for the diagnosis of preeclampsia (Chi et al., 2021). The gene discussed is FLT1; the disease is preeclampsia.